Center-Authored Papers

Filters: Author is Pappo, Alberto S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, Frazier LA, George S, Goldsby R, Hayashi R et al..  2014.  Adolescent and young adult oncology, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(1):21-32. Abstract
M
von Mehren M, Randall LR, Benjamin RS, Boles S, Bui MM, Casper ES, Conrad EU, DeLaney TF, Ganjoo KN, George S et al..  2014.  Gastrointestinal stromal tumors, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(6):853-62. Abstract
P
Pappo AS, Vassal G, Crowley JJ, Bolejack V, Hogendoorn PCW, Chugh R, Ladanyi M, Grippo JF, Dall G, Staddon AP et al..  2014.  A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance. Cancer. Abstract
W
Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan A, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS.  2017.  Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.. Cancer. Abstract